Industry
Drug Manufacturers - Specialty & Generic
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Loading...
Open
7.55
Mkt cap
280M
Volume
142K
High
7.63
P/E Ratio
58.54
52-wk high
8.90
Low
7.19
Div yield
N/A
52-wk low
3.68
Portfolio Pulse from
November 07, 2024 | 12:15 pm
Portfolio Pulse from Benzinga Newsdesk
October 04, 2024 | 4:29 pm
Portfolio Pulse from Nabaparna Bhattacharya
October 04, 2024 | 11:41 am
Portfolio Pulse from Benzinga Newsdesk
October 04, 2024 | 11:37 am
Portfolio Pulse from Nabaparna Bhattacharya
October 04, 2024 | 11:23 am
Portfolio Pulse from Avi Kapoor
October 04, 2024 | 6:15 am
Portfolio Pulse from Benzinga Newsdesk
October 01, 2024 | 11:01 am
Portfolio Pulse from Benzinga Newsdesk
September 12, 2024 | 11:11 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.